Biomarker-Guided Oncology Practice in Non–Small Cell Lung Cancer: Utilization Patterns, Turnaround Time, and Sector-Associated Access Barriers. Journal of Precision Medicine and Health Research, v. 2, n. 2, p. e20, 31 Dec.2025.